ASLAN Pharmaceuticals Ltd. Debt to Equity Ratio 2018-2024 | ASLN
Current and historical debt to equity ratio values for ASLAN Pharmaceuticals Ltd. (ASLN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ASLAN Pharmaceuticals Ltd. debt/equity for the three months ending March 31, 2024 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-03-31 | $0.04B | $-0.02B | -2.17 |
| 2023-12-31 | $0.04B | $-0.01B | -2.85 |
| 2023-09-30 | $0.05B | $-0.00B | -51.62 |
| 2023-06-30 | $0.05B | $0.01B | 7.67 |
| 2023-03-31 | $0.05B | $0.01B | 5.10 |
| 2022-12-31 | $0.05B | $0.01B | 6.31 |
| 2022-09-30 | $0.05B | $0.02B | 2.29 |
| 2022-06-30 | $0.05B | $0.03B | 1.47 |
| 2022-03-31 | $0.05B | $0.05B | 1.02 |
| 2021-12-31 | $0.04B | $0.06B | 0.65 |
| 2021-09-30 | $0.04B | $0.07B | 0.54 |
| 2021-06-30 | $0.00B | 0.00 | |
| 2021-03-31 | $0.02B | $0.08B | 0.26 |
| 2020-12-31 | $0.03B | $-0.01B | -2.58 |
| 2020-09-30 | $0.03B | $-0.01B | -2.15 |
| 2020-06-30 | $0.02B | $-0.01B | -2.87 |
| 2020-03-31 | $0.02B | $-0.00B | -5.66 |
| 2019-12-31 | $0.02B | $-0.00B | -39.70 |
| 2019-09-30 | $0.00B | 0.00 | |
| 2019-06-30 | $0.00B | 0.00 | |
| 2019-03-31 | $0.02B | $0.03B | 0.78 |
| 2018-12-31 | $0.02B | $0.03B | 0.73 |
| 2018-09-30 | $0.02B | $0.04B | 0.41 |
| 2018-06-30 | $0.02B | $0.05B | 0.30 |
| 2018-03-31 | $0.03B | $0.03B | 0.94 |
| 2017-12-31 | $0.02B | $0.04B | 0.45 |
| 2017-09-30 | $0.01B | $0.05B | 0.23 |
| 2017-06-30 | $0.01B | $0.06B | 0.22 |
| 2017-03-31 | $0.01B | $0.03B | 0.39 |
